What Ascent Pharmaceuticals does

Ascent Pharmaceuticals, Inc. is a privately held U.S. generic pharmaceutical manufacturer founded in June 2012 by Dr. Sudhakar Vidiyala and headquartered in Central Islip, New York. The company develops, manufactures, and analyzes a portfolio of 49 generic medicines spanning controlled substances (Schedule II opioids such as oxycodone, hydromorphone, methadone, and buprenorphine products), CNS stimulants (amphetamine, methylphenidate, lisdexamfetamine), antidepressants (SSRIs/SNRIs), anticonvulsants, lipid-lowering agents, and other therapeutic categories. It operates from a single cGMP-compliant facility of more than 309,000 square feet, producing multiple dosage forms including immediate-release, modified-release, and extended-release tablets, capsules, softgels, sublingual films, and oral solutions, supported by DEA registration for controlled substances.

The technology platform centers on advanced oral solid dose manufacturing with high-output equipment such as the KORSCH TRP 700 triple-layer tablet press capable of up to 198,000 tablets per hour, softgel production lines with precise filling and sealing controls, and integrated GMP-compliant packaging and finishing. The R&D function is supported by an India-based partner (Asphar Laboratories) for early-stage formulation and analytical development, while internal capabilities include patents covering abuse-deterrent oral dosage forms, oxygen- and moisture-sensitive blister packaging, progesterone compositions, and levothyroxine stabilization methods.

Ascent operates a pure B2B, asset-light commercial model in which finished products are marketed and distributed through channel partners rather than a direct sales force. Camber Pharmaceuticals serves as the primary commercial partner under the Camber brand, XLCare Pharmaceuticals handles U.S. government healthcare programs (Medicaid, Medicare, federal/state programs), and Lannett has appeared as an additional distribution channel. Pricing is contract-based and not publicly disclosed, with revenue generated through one-time sales of generic pharmaceutical units across therapeutic categories. End customers are healthcare providers and patients reached through standard pharmaceutical wholesale and distribution networks.

Name

Ascent Pharmaceuticals

Legal name

Ascent Pharmaceuticals, Inc.

Website

https://ascentpharm.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

251–500 employees

Short description

Ascent Pharmaceuticals is a U.S. generic drug manufacturer founded in 2012, operating a 309,000+ sq ft cGMP facility in Central Islip, NY, producing 49 generic medicines including controlled substances and CNS stimulants for B2B distribution via Camber, XLCare, and Lannett.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Generic APIs & Intermediates (Active Ingredients) (HLAIABAG), Cardiology & Vascular Specialty Pharmaceuticals (HLAIACAG), Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Generic pharmaceutical manufacturing
• Oral solid dosage forms
• Controlled substance medications
• Generic drug development
• Pharmaceutical contract manufacturing

Headquarters

HQ city

Central Islip

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Infrastructure, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Generic Pharmaceutical Product Sales: Revenue generated from manufacturing and selling generic pharmaceutical products across multiple therapeutic categories including controlled substances, CNS stimulants, opioids, and various other generic medications. Products are distributed through channel partners (Camber, XLCare) and directly under the Ascent brand.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

Core offering

Ascent Pharmaceuticals develops, manufactures, and analyzes high-quality generic medicines at a 309,000+ square foot cGMP-compliant facility in Central Islip, New York. The company produces a portfolio of 49 generic pharmaceutical products spanning multiple dosage forms (tablets, capsules, softgels, films, and oral solutions) across therapeutic categories including CNS stimulants, opioid analgesics, antidepressants, anticonvulsants, and cardiovascular medications. Products are marketed and distributed primarily through channel partners Camber Pharmaceuticals and XLCare Pharmaceuticals, with select products sold under the Ascent brand.

Product overview

Ascent Pharmaceuticals is a generic pharmaceutical company that develops, manufactures, and distributes a broad portfolio of generic medicines. The company operates from a 309,000+ square foot cGMP-compliant facility in Central Islip, New York, producing multiple dosage forms including tablets, capsules, oral solutions, and films across therapeutic areas such as CNS stimulants, opioid analgesics, antidepressants, anticonvulsants, and cardiovascular medications. Products are marketed primarily through commercial partners including Camber Pharmaceuticals, XLCare Pharmaceuticals, and Lannett, with select products sold under the Ascent brand. The portfolio of 49+ generic products includes treatments for ADHD (Amphetamine ER, Methylphenidate), pain management (Hydrocodone, Oxycodone, Hydromorphone), opioid use disorder (Buprenorphine products), mental health (Escitalopram, Sertraline, Paliperidone), and various other therapeutic categories.

Differentiator

Problem solved

Functional benefit

Brands

• Camber: Ascent's commercial products are primarily marketed and distributed under the Camber brand.

Products and services

• Amphetamine ER Capsules Extended-release amphetamine capsules for the treatment of ADHD and narcolepsy, available in multiple dosage strengths (5mg-30mg).
• Amphetamine Tablets Immediate-release amphetamine tablets for ADHD treatment, available in 5mg-30mg strengths.
• Benzonatate Capsules Antitussive capsules for symptomatic relief of cough, available in 100mg, 150mg, and 200mg strengths.
• Bexarotene Capsules Retinoid capsules for cutaneous T-cell lymphoma treatment, 75mg strength.
• Buprenorphine Naloxone Sublingual Film Opioid use disorder treatment film in multiple dosage combinations (2mg/0.5mg to 12mg/3mg).
• Buprenorphine Naloxone Sublingual Tablets Opioid use disorder treatment tablets in 2mg/0.5mg and 8mg/2mg strengths.
• Buprenorphine Sublingual Tablets Opioid agonist tablets for opioid dependence treatment in 2mg and 8mg strengths.
• Carbidopa and Levodopa Tablets Decarboxylase inhibitor combination tablets for Parkinson's disease treatment in multiple strength combinations.
• Dexmethylphenidate HCl ER Capsules Extended-release stimulant capsules for ADHD treatment, available in 5mg-40mg strengths.
• Dronabinol Capsules Cannabinoid capsules for nausea/vomiting associated with chemotherapy and appetite stimulation in HIV/AIDS, 2.5mg-10mg strengths.
• Dutasteride Capsules Benign prostatic hyperplasia treatment capsules, 0.5mg strength.
• Escitalopram Tablets SSRI antidepressant tablets for depression and anxiety disorders in 5mg-20mg strengths.
• Famotidine OTC Tablets Over-the-counter H2 receptor antagonist tablets for heartburn relief, 10mg and 20mg strengths.
• Famotidine Rx Tablets Prescription H2 receptor antagonist tablets, 20mg and 40mg strengths.
• Gabapentin Capsules Anticonvulsant capsules for epilepsy and neuropathic pain, 100mg-400mg strengths.
• Gabapentin Tablets Anticonvulsant tablets for epilepsy and neuropathic pain, 600mg and 800mg strengths.
• Gemfibrozil Tablets Fibric acid derivative tablets for hyperlipidemia treatment, 600mg strength.
• Hydrocodone Bitartrate and Acetaminophen Tablets Opioid analgesic combination tablets for moderate to severe pain, available in 2.5mg/325mg to 10mg/325mg strengths.
• Hydromorphone HCl ER Tablets Extended-release opioid analgesic tablets for severe pain, 8mg-32mg strengths.
• Hydromorphone HCl Oral Solution Narcotic analgesic oral solution, 1mg/mL strength in 473mL containers.
• Hydromorphone HCl Tablets Immediate-release narcotic analgesic tablets, 2mg-8mg strengths.
• Ibuprofen and Famotidine Tablets NSAID/H2-receptor antagonist combination tablets for pain relief with reduced gastric risk, 800mg/26.6mg strength.
• Ibuprofen Capsules NSAID capsules for pain and inflammation relief, 200mg strength.
• Icosapent Ethyl Capsules Lipid-lowering agent capsules for cardiovascular risk reduction, 0.5g and 1g strengths.
• Levothyroxine Sodium Tablets Synthetic thyroid hormone tablets for hypothyroidism, available in 25mcg-300mcg strengths.
• Lisdexamphetamine Dimesylate Capsules Stimulant prodrug capsules for ADHD treatment, 10mg-70mg strengths.
• Lisdexamphetamine Dimesylate Chewable Tablets Chewable stimulant tablets for ADHD treatment in patients who have difficulty swallowing.
• Lubiprostone Capsules Chloride channel activator capsules for chronic idiopathic constipation and IBS, 8mcg and 24mcg strengths.
• Meloxicam Tablets NSAID tablets for osteoarthritis and rheumatoid arthritis, 7.5mg and 15mg strengths.
• Methadone HCl Tablets Opioid analgesic tablets for pain management and opioid use disorder treatment.
• Methylphenidate HCl Chewable Tablets CNS stimulant chewable tablets for ADHD, 2.5mg-10mg strengths.
• Methylphenidate HCl ER Tablets Extended-release CNS stimulant tablets for ADHD, 18mg-54mg strengths.
• Methylphenidate HCl Oral Solution CNS stimulant oral solution, 5mg/5mL and 10mg/5mL strengths.
• Methylphenidate Tablets Immediate-release CNS stimulant tablets for ADHD, 5mg-20mg strengths.
• Omega Caps (Omega-3 Acid Ethyl Esters) Antihyperlipidemic omega-3 fatty acid capsules for hypertriglyceridemia, 1g strength.
• Oxycodone and Acetaminophen Tablets Opioid analgesic combination tablets for moderate to severe pain.
• Oxycodone HCl Oral Solution Narcotic analgesic oral solution, 5mg/5mL strength.
• Oxycodone HCl Tablets Narcotic analgesic tablets, 5mg-30mg strengths.
• Oxymorphone HCl Tablets Opioid analgesic tablets for moderate to severe pain, 5mg and 10mg strengths.
• Paliperidone ER Tablets Atypical antipsychotic extended-release tablets for schizophrenia treatment, 1.5mg-9mg strengths.
• Potassium Chloride ER Tablets Electrolyte supplement extended-release tablets for hypokalemia, 10mEq-20mEq strengths.
• Potassium Chloride Oral Solution Electrolyte supplement oral solution for hypokalemia, 10% and 20% concentrations.
• Potassium Citrate ER Tablets Electrolyte supplement extended-release tablets for renal tubular acidosis, 5mEq-15mEq strengths.
• Rivaroxaban Tablets Anticoagulant tablets for blood clot prevention, 2.5mg and 10mg strengths.
• Sertraline HCl Tablets SSRI antidepressant tablets for depression, PTSD, and anxiety disorders, 25mg-100mg strengths.
• Sodium Oxybate Oral Solution CNS depressant oral solution for narcolepsy (cataplexy) and excessive daytime sleepiness, 0.5g/mL strength.
• Tamsulosin HCl Capsules Alpha-1 adrenergic receptor antagonist capsules for BPH, 0.4mg strength.
• Topiramate Tablets Anticonvulsant tablets for epilepsy and migraine prevention, 25mg-200mg strengths.
• Venlafaxine ER Tablets SNRI extended-release tablets for depression and anxiety disorders, 37.5mg-225mg strengths.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and strategic.

• Camber Pharmaceuticals, Inc.coreChannel Partner/ Reseller/ DistributorStrategic commercial partnership where Ascent's manufacturing excellence and supply execution capabilities are combined with Camber's commercial leadership, marketing strength, and customer-facing expertise. Ascent's commercial products are primarily marketed and distributed under the Camber brand, enabling a coordinated, reliable, and market-responsive approach to serving healthcare partners nationwide.
• XLCare PharmaceuticalscoreChannel Partner/ Reseller/ DistributorPartnership with XLCare Pharmaceuticals to support U.S. government healthcare programs and the patients and communities they serve, including Medicaid, Medicare, and other federal/state healthcare programs.
• Asphar LaboratoriesstrategicStrategic or Co-development PartnerIndia-based R&D counterpart that collaborates with Ascent Pharmaceuticals to support select early-stage formulation and analytical development, enhancing Ascent's product development pipeline.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Lannett Company: US-based generic pharmaceutical manufacturer of comparable scale with a portfolio overlapping Ascent's CNS stimulant, opioid, and cardiovascular generics. Lannett is one of Ascent's distribution channel partners, underscoring direct comparability in product mix and customer base.
• Amneal Pharmaceuticals: US-headquartered generic and specialty pharmaceutical company with a portfolio that directly overlaps Ascent's CNS stimulant, opioid, and injectable offerings. Comparable scale, US manufacturing footprint, and exposure to complex generics and controlled substances.
• Camber Pharmaceuticals: Sister-concern US generic distributor (also under Hetero Labs) and Ascent's primary commercial channel partner. Operates a near-identical generic portfolio across controlled substances, CNS, and pain management — competing head-to-head in the same molecules and customer accounts.
• Glenmark Pharmaceuticals (US): India-headquartered generic manufacturer with a meaningful US commercial presence. Overlapping dosage forms (tablets, capsules, oral solutions) and therapeutic categories including CNS, cardiovascular, and pain.
• Ascend Laboratories (Alkem Labs US arm): US generics subsidiary of Alkem Laboratories with a portfolio and operational footprint closely aligned with Ascent's — private-equity-backed, broad therapeutic mix, and India-linked R&D support. Competes for the same ANDA opportunities and channel relationships.

Broad incumbents

• Endo International: US specialty/generic pharma company with a strong controlled-substance and pain-management franchise (Par Pharmaceutical). Comparable focus on Schedule II generics and complex formulations at greater scale.
• Zydus Pharmaceuticals (USA): US generics arm of Cadila/Zydus, an India-based group with deep R&D ties to Ascent's partner Asphar Laboratories. Portfolio overlaps significantly across cardiovascular, CNS, and pain generics.
• Aurobindo Pharma USA: US arm of one of the largest global generic manufacturers. Overlaps with Ascent across multiple therapeutic categories and dosage forms, but at substantially greater scale and breadth — a relevant comparable for trajectory benchmarking.
• Sun Pharmaceutical Industries (US): India-headquartered global generics leader with significant US operations through Taro Pharmaceutical. Overlaps with Ascent across CNS, cardiovascular, and pain categories; relevant for scale and capacity benchmarking.

Regional players

• Apotex Corp. Canadian-headquartered generic manufacturer with a sizable US business across tablets, capsules, and oral solutions. Overlapping product formats and therapeutic categories, with a comparable focus on quality manufacturing and regulated markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ascent-pharmaceuticals-pty-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ascent Pharmaceuticals